No headlines found.
Cross Country Healthcare to Attend the Oppenheimer 34th Annual Healthcare Conference
Business Wire (Fri, 23-Feb 1:45 PM ET)
Cross Country CEO Featured on 2024 Staffing Industry Analysts' 100 in Staffing List
Business Wire (Thu, 22-Feb 7:30 AM ET)
Cross Country Healthcare Announces Fourth Quarter and Full Year 2023 Financial Results
Business Wire (Wed, 21-Feb 4:15 PM ET)
Business Wire (Thu, 1-Feb 4:15 PM ET)
Business Wire (Tue, 9-Jan 7:30 AM ET)
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.
Cross Country Healthcare trades on the NASDAQ stock market under the symbol CCRN.
As of March 28, 2024, CCRN stock price declined to $18.42 with 69,522 million shares trading.
CCRN has a beta of -0.08, meaning it tends to be less sensitive to market movements. CCRN has a correlation of 0.00 to the broad based SPY ETF.
CCRN has a market cap of $639.65 million. This is considered a Small Cap stock.
Last quarter Cross Country Healthcare reported $414 million in Revenue and $.29 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.02.
In the last 3 years, CCRN stock traded as high as $40.12 and as low as $11.92.
The top ETF exchange traded funds that CCRN belongs to (by Net Assets): CALF, IJR, VTI, IWM, AVUV.
CCRN has underperformed the market in the last year with a return of -23.0%, while the SPY ETF gained +33.6%. In the last 3 month period, CCRN fell short of the market, returning -19.9%, while SPY returned +10.1%. However, in the most recent 2 weeks CCRN has outperformed the stock market by returning +5.1%, while SPY returned +1.7%.
CCRN support price is $17.86 and resistance is $19.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CCRN stock will trade within this expected range on the day.